Catalyst Wire Dossier Catalyst Wire Dossier

Rolcya

denosumab · Sandoz GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rolcya, covering 2025-11-27 to 2025-11-27. Get the full timeline:

Most recent: EMA Authorised: Rolcya (denosumab) — Sandoz GmbH

See pricing